[
    [
        {
            "time": "",
            "original_text": "万一下针的抗癌药物刷屏，公司有没有相关的研究方向？贝达药业：会积极关注该领域的發展情況",
            "features": {
                "keywords": [
                    "抗癌药物",
                    "贝达药业",
                    "研究方向",
                    "关注",
                    "领域"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "万一下针的抗癌药物刷屏，公司有没有相关的研究方向？贝达药业：会积极关注该领域的發展情況",
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 4,
                "Duration": 4,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "贝达药业：目前广东集采征求意见稿纳入了埃克替尼，公司正在积极申诉反馈关于征求意见稿的相关问题。埃克替尼已申报参加今年医保谈判，并已通过核查",
            "features": {
                "keywords": [
                    "贝达药业",
                    "广东集采",
                    "埃克替尼",
                    "医保谈判",
                    "核查"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "贝达药业：目前广东集采征求意见稿纳入了埃克替尼，公司正在积极申诉反馈关于征求意见稿的相关问题。埃克替尼已申报参加今年医保谈判，并已通过核查",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        }
    ]
]